| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 64.84% | 0.47% | 0.57% | 32/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 64.47% | 1.82% | 3.56% | 34/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 62.26% | -8.82% | -0.19% | 34/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 62.38% | -17.56% | -3.35% | 37/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 64.54% | -21.69% | 1.92% | 36/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 63.32% | -25.13% | -7.26% | 36/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 68.28% | -20.73% | -9.77% | 32/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 75.67% | -12.34% | -8.18% | 25/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 82.41% | -8.96% | -2.55% | 18/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 84.57% | -5.4% | -1.81% | 16/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 86.13% | 2% | -0.22% | 12/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 86.32% | -1.56% | -4.65% | 15/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 90.53% | 2% | 1.26% | 6/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 89.4% | 3.4% | 1.94% | 8/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2021-12-31 | 87.69% | 2% | 1.43% | 16/55 | 72.1% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-06-30 | 86.46% | 2% | 2% | 19/55 | 73.72% | 百奥泰 | 95.74% | 行业排名> |

微信公众号
证券之星APP



